Drug profile · INN
defibrotide
DEFITELIO
defibrotide (DEFITELIO) is a adenosine a1 receptor agonist.
EMA: approved Blood and blood forming organs (B01) B01AX01
Patents linked 1
Pipeline programs 8
News articles 0
Drug details — defibrotide
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 1
- Programs
- 8
- Data quality
- 0.83
Quick answer
defibrotide (DEFITELIO) is a adenosine a1 receptor agonist.
Key facts
INN defibrotide
Brand DEFITELIO
Mechanism Adenosine A1 receptor agonist
Target Adenosine receptor A1
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AX01
Mechanism of action
Adenosine A1 receptor agonist
Primary target: Adenosine receptor A1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is defibrotide?
defibrotide (DEFITELIO) is a adenosine a1 receptor agonist.
What is the brand name for defibrotide?
DEFITELIO is a marketed brand name for defibrotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.